Research News | Jul. 21, 2017

FDA Approves BENLYSTA as a Weekly Self-Administered Injection to Treat Lupus

Benlysta SC is the first self-injection lupus treatment that can administered at home once per week.

General News | May. 30, 2017

Make Your Voice Heard on Lupus Drug Development

A tremendous opportunity for individuals with lupus to contribute to lupus drug development by sharing how the disease affects their daily lives.

Research News | Nov. 15, 2016

LFA-Funded Study Helps Expedite Drug Development

This week, LFA-supported researchers will share results of a study that could help expedite the delivery of new and safer therapies to people with lupus.

Research News | Aug. 15, 2016

Phase IIB Clinical Trial of Voclosporin Successfully Achieves Primary Endpoint

Trial results offer hope of a more effective and tolerable treatment option to manage lupus-related kidney disease.

General News | Jul. 08, 2016

New Grant to Increase Minority Participation in Lupus Clinical Trials

The year-long initiative to make research on lupus treatments more inclusive and effective formally began on July 1.

General News | Jun. 16, 2016

$5 Million for Lupus Research Passes Second Critical Hurdle

The provision was approved by the U.S. House of Representatives' Appropriations Committee.

General News | Jun. 01, 2016

Lupus Groups to Host Patient-Focused Drug Development Meeting

Lupus organizations announce groundbreaking collaborative initiative to inform lupus drug development.

Research News | May. 16, 2016

New Study: Predicting Risk of Miscarriage During First Trimester

A new study suggests that testing positive for lupus anticoagulant antibodies in the first trimester of pregnancy is the strongest predictor of pregnancy loss in women with lupus.